Endocrine Research DSIP has been associated with LH, GH, and prolactin release, making it useful for pituitary and reproductive research [4]
Findings describe in-vitro and animal research
But the excitement for peptides, including BPC-157, is very premature: For one thing, the evidence that proponents rave about comes from animal data, not human studies
The fact that both cagrilintide and semaglutide have ~7-day half-lives is what makes CagriSema possible as a single weekly research protocol
But the mere possibility of FDA inspection hasnt historically guaranteed safety: earlier in July, a 27-year-old New York woman died after a botched injection of what was supposed to be an anti-ageing peptide, administered by a proprietor who wasnt licensed to practice in New York